fda statement bpc-157 not approved drug Peptide Approval Process Upheld by CSPI | Peter Lurie posted on the topic An FDA Committee Just Voted

Here are the reasons you are more likely than not to have some degree of gut hyper-permeability syndrome AKA leaky gut. Environmental contaminants and toxins Direct gastrointestinal toxins we consume or absorb such as the methylmercury in canned tuna fish, the excessive use of plastics for food storage and even the fluoride in unfiltered water- can all damage our gut lining and disturb our microbiome

[Abstract]2023 Jan:310:136924

While the committee was originally slated to consider four peptides on Thursday, the meeting was running significantly behind and a third peptide, TB-500 was still being discussed at the time of publication

It is Nisenbaum, not Niesenbaum.

Reported side effects are minimal, but some users in experimental settings have described: Mild fatigue Temporary nausea Headache or dizziness Long-Term Risks The long-term impact of MOTS-c therapy remains unknown, raising concerns about possible risks from prolonged use: Metabolic Overstimulation: chronic AMPK activation may interfere with natural energy signaling